Kristina Krassman is battling two diseases that cause extreme pain in her stomach and abdomen when she tries to eat.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stock has reached a new 52-week low, touching down at $30.86, with InvestingPro data showing the stock trading at $30.89, significantly below its 52-week high ...

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, February 19th. Analysts expect Ionis Pharmaceuticals to post ...

Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only-mode. At the end of the prepared ...

Feb. 12, 2025 — Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and ...

Rehabilitation of the patient with glenohumeral impingement requires a complete understanding of the structures involved and the underlying mechanism creating the impingement response. A detailed ...

Faced with the earlier setbacks with Nuplazid, the company has worked to add to its pipeline, and is hoping for FDA approval of its trofinetide candidate for neurological disorder Rett syndrome in ...

5 Division of Physical Therapy, University of Kentucky, Lexington, Kentucky, USA 6 Department of Physical Therapy, Carroll University, Waukesha, Wisconsin, USA 7 Department of Physical Therapy, East ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Sumitomo Mitsui Trust Group Inc. lessened its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 20.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor ...